V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001279 | 330000717 | null | 120.3 | Curative (C) | null | 2016-03-19 | OST Euramos 1 Closed Trial - Ai | 02 | N | 330003240 | NOT MATCHED |
| 330001280 | 330000718 | 1.7 | 14.3 | null | 2016-02-06 | 2016-02-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003244 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001281 | 330000719 | 1.62 | 79.1 | Neo-adjuvant (N) | 2013-04-30 | 2013-05-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330003246 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001282 | 330000720 | 1.88 | 17 | Curative (C) | 2014-12-25 | 2015-01-08 | Cisplatin | 02 | null | 330003249 | CISPLATIN |
| 330001283 | 330006438 | 1.81 | 81 | Curative (C) | 2016-01-16 | 2016-01-22 | Cisplatin | 02 | Y | 330003251 | CISPLATIN |
| 330001284 | 330000721 | null | 93 | Neo-adjuvant (N) | 2017-10-21 | 2017-10-21 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003254 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001285 | 330000722 | 1.54 | 47.8 | Curative (C) | 2017-03-11 | 2017-03-18 | Trial Unspecified | N | null | 330003256 | TRIAL |
| 330001286 | 330006439 | 0 | 88 | Curative (C) | 2017-05-09 | 2017-05-19 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330003258 | NOT MATCHED |
| 330001287 | 330000723 | 1.57 | 50.1 | Curative (C) | 2015-02-15 | 2015-02-16 | Cisplatin | N | Y | 330003260 | CISPLATIN |
| 330001288 | 330000723 | 1.71 | 11.2 | Curative (C) | 2015-12-30 | 2015-12-30 | Cisplatin | 02 | Y | 330003260 | CISPLATIN |
| 330001289 | 330000724 | 1.81 | 55.9 | Neo-adjuvant (N) | null | 2016-07-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003263 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001290 | 330000724 | 1.67 | 77.2 | Curative (C) | 2014-10-10 | 2014-11-10 | Cisplatin 7 day | N | Y | 330003263 | CISPLATIN |
| 330001291 | 330000725 | 1.78 | 68.4 | Neo-adjuvant (N) | 2016-12-26 | 2017-01-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330003267 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001292 | 330000726 | 1.59 | 26.4 | Not known (9) | 2013-12-07 | 2013-12-20 | Trial Unspecified | 02 | null | 330003268 | TRIAL |
| 330001293 | 330000726 | null | 74.4 | Curative (C) | null | 2013-06-18 | Cisplatin 7 day | N | Y | 330003268 | CISPLATIN |
| 330001294 | 330000727 | 1.61 | 9.3 | null | 2015-04-27 | 2015-04-27 | Cisplatin 7 day | N | Y | 330003274 | CISPLATIN |
| 330001295 | 330000728 | null | 50.1 | Curative (C) | null | 2015-10-06 | Cisplatin 7 day | null | Y | 330003276 | CISPLATIN |
| 330001296 | 330000729 | 1.72 | 63.4 | null | 2014-01-17 | 2014-01-27 | EW EuroEwing 2012 Arm B VDC | Y | N | 330003278 | TRIAL |
| 330001297 | 330000729 | null | null | Curative (C) | 2013-05-31 | 2013-06-07 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330003278 | NOT MATCHED |
| 330001299 | 330000731 | 1.69 | 5.5 | Neo-adjuvant (N) | null | 2015-03-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003283 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001300 | 330000732 | 1.65 | 59 | Curative (C) | 2014-04-07 | 2014-05-05 | Cisplatin | 02 | Y | 330003285 | CISPLATIN |
| 330001302 | 330006444 | 1.78 | 68.9 | null | 2016-05-06 | 2016-05-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003292 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001303 | 330006444 | 1.7 | 72.3 | Curative (C) | 2016-07-25 | 2016-08-22 | Cisplatin | N | Y | 330003292 | CISPLATIN |
| 330001304 | 330006444 | 1.6 | 55.65 | Curative (C) | null | 2017-09-01 | Cisplatin | 02 | Y | 330003292 | CISPLATIN |
| 330001305 | 330000734 | null | 75.5 | Curative (C) | 2014-02-17 | 2014-02-20 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 330003299 | NOT MATCHED |
| 330001306 | 330000735 | 1.7 | null | Curative (C) | 2013-02-12 | 2013-02-15 | Cisplatin 7 day | N | Y | 330003301 | CISPLATIN |
| 330001307 | 330000735 | 1.8 | 16.1 | Adjuvant (A) | 2014-08-16 | 2014-09-17 | Cisplatin | N | N | 330003301 | CISPLATIN |
| 330001308 | 330000736 | 1.69 | 69.5 | Neo-adjuvant (N) | null | 2013-09-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003304 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001309 | 330000737 | 1.58 | 28 | Curative (C) | 2016-06-28 | 2016-07-27 | Cisplatin 7 day | Y | Y | 330003306 | CISPLATIN |
| 330001310 | 330000738 | 1.8 | 74.2 | Not known (9) | 2017-07-31 | 2017-08-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003309 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001311 | 330000739 | 0 | 11.3 | Curative (C) | 2017-02-05 | 2017-02-17 | AML MyeChild 01 A Mitozantrone/Cytarabine | Y | N | 330003313 | NOT MATCHED |
| 330001313 | 330006446 | null | 9.7 | Neo-adjuvant (N) | 2018-06-22 | 2018-07-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330003323 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001314 | 330006446 | 1.6 | 55 | Curative (C) | 2013-07-09 | 2013-07-09 | Cisplatin 7 day | N | Y | 330003323 | CISPLATIN |
| 330001315 | 330000741 | null | 73.9 | Curative (C) | 2014-01-17 | 2014-01-19 | CNS GCT II | N | N | 330003325 | NOT MATCHED |
| 330001316 | 330000741 | 1.68 | 27.4 | Curative (C) | 2018-01-18 | 2018-02-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 330003325 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001317 | 330000742 | 1.04 | 15.1 | Curative (C) | 2013-08-09 | 2013-08-13 | LCH guideline Gp1 Continuation treatment | Y | N | 330003329 | NOT MATCHED |
| 330001318 | 330000743 | 1.68 | 96.7 | Neo-adjuvant (N) | 2015-12-13 | 2015-12-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003331 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001319 | 330000744 | null | 56.2 | Curative (C) | 2013-10-23 | 2013-10-23 | NB HRNBL-1 COJEC Ind COURSE A | null | N | 330003334 | NOT MATCHED |
| 330001320 | 330000744 | null | 82.3 | Adjuvant (A) | 2016-08-27 | 2016-09-23 | Cisplatin | 02 | N | 330003334 | CISPLATIN |
| 330001321 | 330000745 | 1.82 | null | Disease modification (D) | 2014-03-16 | 2014-03-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003341 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001322 | 330000746 | null | 63 | Curative (C) | 2012-11-22 | 2013-08-10 | NB Low/Interm risk guidelines Carbo/Etop | N | Y | 330003344 | NOT MATCHED |
| 330001323 | 330000747 | 1.6 | 50 | Neo-adjuvant (N) | 2014-04-02 | 2014-04-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003346 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001324 | 330000747 | 1.59 | 45.8 | Curative (C) | 2015-04-30 | 2015-06-04 | Cisplatin 7 day | null | N | 330003346 | CISPLATIN |
| 330001325 | 330000748 | 1.75 | null | Neo-adjuvant (N) | 2016-01-10 | 2016-01-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330003348 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001326 | 330000749 | null | 65 | Curative (C) | 2014-01-22 | 2014-01-22 | EW EuroEwing 2012 Arm A VAC | 2 | N | 330003349 | NOT MATCHED |
| 330001327 | 330000749 | 1.72 | null | Curative (C) | 2014-07-09 | 2014-07-15 | Cisplatin | N | Y | 330003349 | CISPLATIN |
| 330001328 | 330000750 | null | 12.4 | Curative (C) | 2015-05-18 | 2015-05-18 | CNS LGG 2004 03 cons vinc + carbo | N | N | 330003353 | NOT MATCHED |
| 330001329 | 330000750 | 0 | 71.3 | Disease modification (D) | 2013-09-20 | 2013-09-20 | Trial Unspecified | null | N | 330003353 | TRIAL |
| 330001330 | 330000751 | 1.82 | 63 | Curative (C) | 2017-08-06 | 2017-08-09 | NB Rel CCLG guidelines Irin & Temoz | Y | N | 330003355 | NOT MATCHED |
| 330001331 | 330000752 | 1.72 | 53.4 | Neo-adjuvant (N) | 2014-08-06 | 2014-09-01 | Cisplatin | 02 | Y | 330003356 | CISPLATIN |